Stanford eye scientist Dr. Jeffrey Goldberg on why vision restoration, not just slowing eye disease, is about to arrive.

Dr. Jeffrey Goldberg — Stanford ophthalmologist and vision researcher specializing in glaucoma, optic nerve degeneration, and the science of restoring and enhancing sight; chair of Stanford Ophthalmology.
Tim Ferriss talks with Stanford ophthalmologist Dr. Jeffrey Goldberg, recruited via a social post about presbyopia (age-related near-vision decline). They cover the basic anatomy of the eye and the spectrum from sick to normal to 'supra-normal' vision, including frame-rate-reducing goggles that train athletes' reflexes. Goldberg surveys the evidence on supplements (AREDS2, vitamin B3/nicotinamide), red and violet light therapy for mitochondria and myopia, pilocarpine-style pupil-constricting eye drops, dry-eye treatments, and serum tears. He explains glaucoma as the number-one cause of irreversible blindness, eye-pressure variability, cannabis's temporary pressure-lowering effect, and the surprising role of the innate immune system and gut microbiome in neurodegeneration. The big thesis: the long-held belief that lost vision can't be recovered is about to topple, with stem-cell and plasticity-based vision restoration moving into human trials within five years.
Books, products and media the guest or host genuinely endorsed here — with the buy link.
Affiliate link — we may earn a commission at no extra cost to you.
“we usually recommend at that stage switch over to preservative free artificial tears because it turns out that preservative in those bottles of drops at a lot of drops a day, the preservative is actually irritating” — Dr. Jeffrey Goldberg 00:59:54Find it on Amazon